Discovery of Potent and Selective RSK Inhibitors as Biological Probes
about
MAPK-Activated Protein Kinases (MKs): Novel Insights and ChallengesDevelopment of a RSK Inhibitor as a Novel Therapy for Triple-Negative Breast Cancer.RSK-mediated down-regulation of PDCD4 is required for proliferation, survival, and migration in a model of triple-negative breast cancer.Human melanoma cells resistant to MAPK inhibitors can be effectively targeted by inhibition of the p90 ribosomal S6 kinaseRibosomal S6 kinase (RSK) modulators: a patent review.Structural characterization of human Vaccinia-Related Kinases (VRK) bound to small-molecule inhibitors identifies different P-loop conformations.Molecular modeling and structure-based drug discovery approach reveals protein kinases as off-targets for novel anticancer drug RH1.Differential control of Toll-like receptor 4-induced interleukin-10 induction in macrophages and B cells reveals a role for p90 ribosomal S6 kinases.RSK2 is a new Pim2 target with pro-survival functions in FLT3-ITD-positive acute myeloid leukemia.Dehydroabietic oximes halt pancreatic cancer cell growth in the G1 phase through induction of p27 and downregulation of cyclin D1
P2860
Q26771339-A4D3B0EB-40BC-4EF4-9DC0-6CDAEC88A594Q30275521-4938C9B5-52E4-408B-AF8D-A3DA7C3F4BBEQ37317329-1ADABCB4-BDF7-4B1B-A9B3-0CE7D4E4686EQ38834031-DB3A5079-8C6C-4F86-B588-DEF667DEB5EFQ38895271-E04CEAC7-9426-48F2-8FFC-1448414BCB11Q41309405-1C0544B5-7BF8-4AA7-90B8-C4A13CD0C95EQ46311028-6FEC4DB2-62EA-43F5-9863-A8BD9D51FF6EQ47304997-1715B8AE-6D08-4FC8-8BEF-F235409B6EDDQ47797184-4A2E256D-E06F-409E-B5AB-8300F71A53CEQ58107347-A578DD4B-5D68-4640-8C0D-4C36FD75F757
P2860
Discovery of Potent and Selective RSK Inhibitors as Biological Probes
description
2015 nî lūn-bûn
@nan
2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Discovery of Potent and Selective RSK Inhibitors as Biological Probes
@ast
Discovery of Potent and Selective RSK Inhibitors as Biological Probes
@en
Discovery of Potent and Selective RSK Inhibitors as Biological Probes
@nl
type
label
Discovery of Potent and Selective RSK Inhibitors as Biological Probes
@ast
Discovery of Potent and Selective RSK Inhibitors as Biological Probes
@en
Discovery of Potent and Selective RSK Inhibitors as Biological Probes
@nl
prefLabel
Discovery of Potent and Selective RSK Inhibitors as Biological Probes
@ast
Discovery of Potent and Selective RSK Inhibitors as Biological Probes
@en
Discovery of Potent and Selective RSK Inhibitors as Biological Probes
@nl
P2093
P3181
P1476
Discovery of Potent and Selective RSK Inhibitors as Biological Probes
@en
P2093
Abran Costales
Anne B Jefferson
Cynthia M Shafer
Gordana Atallah
Laura Doyle
Lina Setti
Michelle Mathur
Mika Lindvall
P304
P3181
P356
10.1021/ACS.JMEDCHEM.5B00450
P407
P577
2015-09-10T00:00:00Z